Skip to main content

Bilal Arif

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bilal Arif

Sarepta Therapeutics, Inc. reported in an 8-K filed August 13, 2025 that Bilal Arif was terminated as Executive Vice President, Chief Technical Operations Officer, effective September 16, 2025. Sarepta Therapeutics, Inc. reported in an 8-K filed November 2, 2022 that Bilal Arif was appointed Chief Technical Operations Officer, effective December 31, 2022. The proxy statement of Sarepta Therapeutics, Inc. reports total compensation of $2,539,138 for Bilal Arif in fiscal 2024, including a base salary of $545,200. Disclosed compensation is on record for 4 fiscal years.

“Bilal Arif’s employment will end effective September 16, 2025.”
Sarepta Therapeutics, Inc. Form 8-K, filed August 13, 2025 · Read the filing
“On October 31, 2022, the Board appointed Bilal Arif, the Company's Senior Vice President, Strategy and Operations, as the Company's Chief Technical Operations Officer, effective as of December 31, 2022 and upon Mr. Ciambrone's retirement.”
Sarepta Therapeutics, Inc. Form 8-K, filed November 2, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Sarepta Therapeutics, Inc. (SRPT) $545,200 $2,539,138
2023 Sarepta Therapeutics, Inc. (SRPT) $514,112 $3,520,586
2022 Sarepta Therapeutics, Inc. (SRPT) — —
2021 Sarepta Therapeutics, Inc. (SRPT) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.